Christopher Cottrell

Across four preclinical studies, Scripps Research, IAVI, and additional collaborators make headway in stimulating the rare antibodies needed to fight HIV.

Scripps Research, IAVI, Fred Hutch, VRC and other collaborators publish study data in Science, helping validate novel vaccination strategy.

The new method by scientists at Scripps Research identifies specific antibodies in immune responses to vaccination or infection in fraction of time needed for traditional approach.

New understanding of how off-target antibodies hinder HIV vaccines’ success drives design improvements.

The technique should help in the design of vaccines against HIV, SARS-CoV-2 and other viruses that cloak their outer proteins with sugars to evade antibodies.

The Skaggs Graduate School of Chemical and Biological Sciences awarded doctorates to 44 young scientists who comprise the 28th graduating class at Scripps Research. In lieu of the traditional annual commencement ceremony, a virtual celebration will be held in July.

Scientists at Scripps Research have solved the structure of a key protein that senses when our cells swell.

"We can now watch antibody responses evolve almost in real time."